A share price of Onconova Therapeutics Inc [ONTX] is currently trading at $1.00, down -0.47%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ONTX shares have gain 13.12% over the last week, with a monthly amount glided 19.93%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 2, April 2024, Traws Pharma Announces New Employee Inducement Grants. In a post published today on Yahoo Finance, Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onconova Therapeutics, Inc. (the “Merger”).
From an analyst’s perspective:
Onconova Therapeutics Inc [NASDAQ: ONTX] stock has seen the most recent analyst activity on March 01, 2022, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $7. Previously, Guggenheim started tracking the stock with Buy rating on May 18, 2021, and set its price target to $4. On March 01, 2018, H.C. Wainwright reiterated its Buy rating and revised its price target to $7.50 on the stock. Maxim Group downgraded its rating to a Hold. H.C. Wainwright initiated its recommendation with a Buy and recommended $6 as its price target on October 09, 2017. Laidlaw started tracking with a Buy rating for this stock on April 27, 2017, and assigned it a price target of $10. In a note dated July 01, 2015, Piper Jaffray upgraded an Overweight rating on this stock.
Onconova Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.55 and $1.45. Onconova Therapeutics Inc [NASDAQ: ONTX] shares were valued at $1.00 at the most recent close of the market.
Analyzing the ONTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.93% with Operating Profit Margin at -95.44%, Pretax Profit Margin comes in at -89.31%, and Net Profit Margin reading is -85.85%. To continue investigating profitability, this company’s Return on Assets is posted at -0.72, Equity is -0.92 and Total Capital is -1.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.8405 points at the first support level, and at 0.6858 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.0750, and for the 2nd resistance point, it is at 1.1548.
Onconova Therapeutics Inc [ONTX] reported earnings per share of -$0.19 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.25/share, meaning a difference of $0.06 and a surprise factor of 24.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.23 per share as compared to estimates of -$0.29 per share, a difference of $0.06 representing a surprise of 20.70%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Onconova Therapeutics Inc [NASDAQ:ONTX] is 2.46. Further, the Quick Ratio stands at 2.46, while the Cash Ratio is 2.61. Considering the valuation of this stock, the price to sales ratio is 90.88, the price to book ratio is 1.96.
